LLY

1,105.05

-0.35%↓

JNJ

207.73

+0.45%↑

ABBV

227.54

-1.85%↓

UNH

329.68

+1.07%↑

AZN

93.37

+0.12%↑

LLY

1,105.05

-0.35%↓

JNJ

207.73

+0.45%↑

ABBV

227.54

-1.85%↓

UNH

329.68

+1.07%↑

AZN

93.37

+0.12%↑

LLY

1,105.05

-0.35%↓

JNJ

207.73

+0.45%↑

ABBV

227.54

-1.85%↓

UNH

329.68

+1.07%↑

AZN

93.37

+0.12%↑

LLY

1,105.05

-0.35%↓

JNJ

207.73

+0.45%↑

ABBV

227.54

-1.85%↓

UNH

329.68

+1.07%↑

AZN

93.37

+0.12%↑

LLY

1,105.05

-0.35%↓

JNJ

207.73

+0.45%↑

ABBV

227.54

-1.85%↓

UNH

329.68

+1.07%↑

AZN

93.37

+0.12%↑

Strona główna・Stock List・Progyny Inc

Progyny Inc

Closed

SectorHealthcare

26.71 -0.19

Buy Sell

Overview

Share price change

24h

Current

Min

26.51

Max

26.94

Key metrics
By Trading Economics
Income	-3.2M 14M
Sales	-20M 313M
P/E Sector Avg	42.468 79.874
EPS	0.45
Profit margin	4.425
Employees	675
EBITDA	-3.1M 25M

Recommendations
By TipRanks
Recommendations	Buy
12 Months Forecast	+6.74% upside

Market Stats
By TradingEconomics
Market Cap	685M 2.3B
Previous open	26.9
Previous close	26.71

News Sentiment

By Acuity

32%

68%

98 / 374 Ranking in Healthcare

Technical Score

By Trading Central

Confidence

Strong Bullish Evidence

22.91 / 23.375 Support & Resistance

Progyny Inc Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

27 lis 2025, 16:49 UTC

Acquisitions, Mergers, Takeovers

Deutsche Boerse in Talks to Buy Fund-Tech Platform Allfunds in $6 Billion Deal

27 lis 2025, 15:32 UTC

Acquisitions, Mergers, Takeovers

TotalEnergies, Repsol in Talks to Combine U.K. North Sea Assets, Cinco Dias Says, Citing Sources

27 lis 2025, 23:50 UTC

Market Talk

Nikkei May Trade Rangebound Amid Caution Over Economic Outlook -- Market Talk

27 lis 2025, 23:50 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

27 lis 2025, 16:05 UTC

Market Talk

Canadian Job Vacancies Rise for Fist Time Since Start of 2024 -- Market Talk

27 lis 2025, 16:04 UTC

Market Talk

Canadian Payroll Employment Pulls Back in September, Offsetting Recent Gains -- Market Talk

27 lis 2025, 15:54 UTC

Acquisitions, Mergers, Takeovers

Allfunds Shares Rise 21% After Deutsche Boerse Says Started Acquisition Talks

27 lis 2025, 15:44 UTC

Acquisitions, Mergers, Takeovers

Deutsche Boerse: No Certainty Talks Will Result in Transaction

27 lis 2025, 15:43 UTC

Acquisitions, Mergers, Takeovers

Deutsche Boerse: Allfunds Board of Directors Has Agreed to Enter Exclusive Talks

27 lis 2025, 15:42 UTC

Acquisitions, Mergers, Takeovers

Deutsche Boerse: Nonbinding Proposal is To Acquire Allfunds at EUR8.80 a Share

27 lis 2025, 15:41 UTC

Acquisitions, Mergers, Takeovers

Deutsche Boerse in Talks With Allfunds on Possible Acquisition

27 lis 2025, 15:11 UTC

Market Talk

Dollar Could Fall in 2026 as U.S. Rate Cuts Bite -- Market Talk

27 lis 2025, 14:26 UTC

Market Talk

Hermes' Outperformance Gap Could Narrow -- Market Talk

27 lis 2025, 14:11 UTC

Market Talk

Lack of Major Budget Surprises Don't Justify Continued Sterling Strength -- Market Talk

27 lis 2025, 14:11 UTC

Market Talk

Market Talk Roundup: Latest on U.S. Politics

27 lis 2025, 13:35 UTC

Market Talk

Richemont Looks Set to Continue Outgrowing Peers -- Market Talk

27 lis 2025, 13:33 UTC

Market Talk

Sterling's Post-Budget Gains Are Probably Over -- Market Talk

27 lis 2025, 13:22 UTC

Market Talk

Global Equities Roundup: Market Talk

27 lis 2025, 13:22 UTC

Market Talk

Kering's Plan to Revive Gucci Needs More Clarity -- Market Talk

27 lis 2025, 13:17 UTC

Market Talk

LVMH Should Be Able to Recover Next Year -- Market Talk

27 lis 2025, 11:13 UTC

Market Talk

European Gas Prices Come Under Pressure -- Market Talk

27 lis 2025, 11:07 UTC

Earnings

Genting: Positive About Prospects Over Longer Term

27 lis 2025, 11:06 UTC

Earnings

Genting: Cautious on Near-Term Prospects of Leisure, Hospitality Industry

27 lis 2025, 11:04 UTC

Earnings

Genting: International Travel Demand Expected to Remain Resilient

27 lis 2025, 11:04 UTC

Earnings

Genting: Global Growth Expected to Remain Subdued

27 lis 2025, 11:04 UTC

Earnings

Genting: Ebitda Partly Weighed by Stronger Ringgit Vs. Singapore Dollar, British Pound, U.S. Dollar

27 lis 2025, 10:59 UTC

Earnings

Genting Bhd 3Q Net Profit Fell 86% on Year

27 lis 2025, 10:58 UTC

Earnings

Genting Bhd 3Q Rev Rose 14% on Year

27 lis 2025, 10:56 UTC

Earnings

Genting Bhd 3Q Net MYR30.3M

27 lis 2025, 10:56 UTC

Earnings

Genting Bhd 3Q EPS MYR0.0079

Peer Comparison

Price change

Progyny Inc Forecast

Price Target

By TipRanks

6.74% upside

12 Months Forecast

Average 28.5 USD 6.74%

High 33 USD

Low 26 USD

Based on 8 Wall Street analysts offering 12 month price targets forProgyny Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

8 ratings

Buy

Hold

Sell

Based on 8 analysts giving stock ratings to Progyny Inc - Dist in the past 3 months.

Technical Score

By Trading Central

22.91 / 23.375Support & Resistance

Bullish events outweigh bearish events.

Recent bullish events outweigh bearish events.

Sentiment

By Acuity

98 / 374 Ranking in Healthcare

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

About Progyny Inc

Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides its members with access to the medications needed during their treatment. In addition, it provides assistance service programs where various services can be offered through a reimbursement program, including adoption, surrogacy, doula, and travel reimbursement when travel is required to receive medical services. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.